BP000302-CHM-350: Recombinant Human C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: E. coli-derived.
The ED50 of CXCL4 as determined by its ability to inhibit human FGF basic dependent proliferation of NR6R3T3 mouse fibroblasts was found to be 5-15 ?/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000302-CHM-245: Recombinant Mouse C-X-C Motif Chemokine Ligand 4 (CXCL4) Protein
Source: E. coli-derived.
Purity: > 97% by RP-HPLC and SDS-PAGE.BP000267-CHM-356: Recombinant Human C-X-C Motif Chemokine 2 (CXCL2) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000267-CHM-338: Recombinant Mouse C-X-C Motif Chemokine 2 (CXCL2) Protein
Source: E. coli-derived.
The Biological activity was determined by its ability to chemoattract total human neutrophils using a concentration range of 1.0-10.0 ug/ml, corresponding to a specific activity of 105-106 units/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000267-CHM-309: Recombinant Human C-X-C Motif Chemokine 2 (CXCL2) Protein
Source: E. coli-derived.
The Biological activity is calculated by its ability to chemoattract CXCR2 transfected 293 cells using 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000267-CHM-372: Recombinant Rat C-X-C Motif Chemokine 2 (CXCL2) Protein
Source: E. coli-derived.
The biological activity was determined by its ability to chemoattract total human neutrophils using a concentration range of 1.0-10.0 ug/ml, corresponding to a specific activity of 100,000-1,000,000 units/mg.
Purity: > 99% by SDS-PAGE.BP000294-CHM-363: Recombinant Mouse C-X-C Motif Chemokine 16 (CXCL16) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract murine lymphocytes using a concentration range of 100-1000 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000289-CHM-001: Recombinant Human C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
The ED50 of CXCL14 as determined by its ability to induce calcium flux of prostaglandin E2 treated THP1 human acute monocytic leukemia cells was 1.0-10.0 ug/ml.
N-terminal sequence analysis: Ser-Lys-Cys-Lys-Cys.
Predicted molecular mass: 9.4 kDa.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000289-CHM-007: Recombinant Mouse C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
The ED50 of CXCL14 as determined by its ability to chemoattract activated monocytes was using a concentration range of 1.0-10.0 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000289-CHM-239: Recombinant Human C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein, His-Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.
Formulation: filtered (0.4 ?) and lyophilized from a concentrated (0.5 ug/ml) solution containing 20 mM Tris buffer & 20 mM NaCl pH-7.5.